Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0219
NEWS & VIEWS
|
Pre-treatment diagnostics of esophageal cancer and the role of EUS. |
|
Affiliation: Prof. Dr.med. Ernst Hanisch, Chefarzt und Ärztlicher Direktor, Klinik für Allgemein- Viszeral- und Endokrine Chirurgie, Asklepios Klinik Langen, Akademisches Lehrkrankenhaus der JWG-Universität Frankfurt, Röntgenstr 20, 63225 Langen.
Tel: 06103/912 61200; FAX: 06103/9121814,
Email: E.Hanisch@Asklepios.com |
Since there is no abstract available we provide the first paragraph.
Despite sensitivity and high response rate to neoadjuvant chemotherapy or chemoradiotherapy in esophageal cancer, pre-treatment identification of responder patients still remains a grand challenge. Could endoscopic ultrasound (EUS) be useful before, during and after completion of neoadjuvant treatment be used for monitoring the disease and improving therapeutic decisions?
(Citation: Gastric & Breast Cancer 2012; 11(2): 91-93)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 23 April 2012 |
|
